Quest Diagnostics Inc
(DGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,332 | 238,879 | 174,165 | 120,730 | 171,477 |
| Receivables | 508,340 | 513,637 | 520,873 | 509,272 | 485,573 |
| Inventories | 49,906 | 46,188 | 44,456 | 45,161 | 44,274 |
| Income taxes - deferred | 157,649 | 148,182 | 167,579 | 185,533 | 188,483 |
| TOTAL | $876,514 | $988,405 | $956,660 | $952,814 | $980,689 |
| Non-Current Assets | |||||
| PPE Net | 508,619 | 493,197 | 486,839 | 473,064 | 449,856 |
| Intangibles | 1,379,143 | 1,282,678 | 1,293,469 | 1,297,679 | 1,261,603 |
| Other Non-Current Assets | 166,279 | 169,190 | 161,457 | 179,678 | 172,388 |
| TOTAL | $2,054,041 | $1,945,065 | $1,941,765 | $1,950,421 | $1,883,847 |
| Total Assets | $2,930,555 | $2,933,470 | $2,898,425 | $2,903,235 | $2,864,536 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,404 | 280,618 | 287,747 | 265,030 | 265,408 |
| Accounts payable and accrued liabilities | 657,219 | 608,047 | 602,312 | 654,989 | 689,582 |
| TOTAL | $658,623 | $888,665 | $890,059 | $920,019 | $954,990 |
| Non-Current Liabilities | |||||
| Long Term Debt | 820,337 | 677,913 | 726,673 | 758,481 | 760,705 |
| Other Non-Current Liabilities | 115,608 | 122,970 | 120,820 | 124,519 | 117,046 |
| TOTAL | $935,945 | $800,883 | $847,493 | $883,000 | $877,751 |
| Total Liabilities | $1,594,568 | $1,689,548 | $1,737,552 | $1,803,019 | $1,832,741 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 192,586 | 191,143 | 189,479 | 187,945 | N/A |
| Common Shares | 960 | 954 | 945 | 469 | 465 |
| Retained earnings | -362,926 | -413,834 | -463,927 | -489,392 | -525,111 |
| Other shareholders' equity | -16,723 | -20,792 | -26,248 | -37,977 | -36,535 |
| TOTAL | $1,335,987 | $1,243,922 | $1,160,873 | $1,100,216 | $1,031,795 |
| Total Liabilities And Equity | $2,930,555 | $2,933,470 | $2,898,425 | $2,903,235 | $2,864,536 |